reveromycin a has been researched along with Alveolar Bone Atrophy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, Y; Goto, S; Kako, S; Kawatani, M; Maeda, H; Miyazawa, K; Osada, H; Tabuchi, M | 1 |
| Goto, S; Kadota, M; Kawatani, M; Maeda, H; Miyazawa, K; Osada, H; Shoji, S; Tabuchi, M; Tanaka, M; Yabumoto, T; Yoshizako, M | 1 |
| Goto, S; Kawatani, M; Maeda, H; Minamoto, C; Miyazawa, K; Mizuno, M; Osada, H; Tabuchi, M; Tamaoka, Y; Tanaka, M; Torii, Y; Yoshizako, M | 1 |
3 other study(ies) available for reveromycin a and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Local administration of ReveromycinA ointment suppressed alveolar bone loss in mice.
Topics: Administration, Topical; Alveolar Bone Loss; Animals; Bone Resorption; Disease Models, Animal; Male; Mice, Inbred C57BL; Mice, Knockout; Ointments; Osteoclasts; Periodontal Diseases; Periodontitis; Pyrans; Spiro Compounds | 2021 |
Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice.
Topics: Alveolar Bone Loss; Animals; Antimitotic Agents; Bone Remodeling; Core Binding Factor Alpha 1 Subunit; Dental Stress Analysis; Disease Models, Animal; Injections, Intraperitoneal; Male; Mice; Mice, Knockout; Osteitis Deformans; Osteoprotegerin; Pyrans; Secondary Prevention; Spiro Compounds; Tooth Movement Techniques | 2013 |
Reveromycin A Administration Prevents Alveolar Bone Loss in Osteoprotegerin Knockout Mice with Periodontal Disease.
Topics: Alveolar Bone Loss; Animals; Cytokines; Disease Models, Animal; Inflammation Mediators; Male; Mice; Mice, Knockout; Osteoclasts; Osteoprotegerin; Periodontal Diseases; Pyrans; Spiro Compounds; X-Ray Microtomography | 2015 |